CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 12 enrolled
Drug / intervention
Nicotine Replacement Therapy +1 moredrug
Likely dose
Nicotine Replacement Therapy 21 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01292642
NCT01292642Phase 2Completed

Cognitive Behavioral Therapy and the Nicotine Transdermal Patch for Cannabis Dependence and Nicotine Dependence

Mclean Hospital·interventional·Posted Feb 9, 2011·Updated Aug 14, 2013

In Brief

A Phase 2 clinical trial evaluating Cognitive Behavioral Therapy and Nicotine Replacement Therapy for Cannabis Dependence and Nicotine Dependence. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The investigators are conducting a Stage 1 pilot feasibility study at McLean Hospital to develop and refine a Cognitive Behavioral Therapy (CBT) intervention. The investigators aim to develop a feasible 10-week integrated CBT intervention for the treatment of concurrent marijuana dependence and nicotine dependence. The investigators hypothesize that the CBT intervention, in conjunction with Nicotine Replacement Therapy (NRT) in the form of a transdermal nicotine patch, will reduce the use of marijuana and nicotine.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 9, 2011
Enrollment StartAug 1, 2009
Primary CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 15.4 years ago

Interventions

Cognitive Behavioral Therapybehavioral

individual CBT once weekly, 50 minutes, for 10 weeks

Nicotine Replacement Therapydrug

1. 21 mg patch for 6 weeks, 14 mg patch for 2 weeks, then 7 mg patch for 2 weeks 2. 14 m g patch for 8 weeks, then 7 mg patch for 2 weeks